We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+15.56%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$883B
AUM Growth
+$71.1B
Cap. Flow
-$18.2B
Cap. Flow %
-2.06%
Top 10 Hldgs %
35.83%
Holding
3,193
New
153
Increased
2,010
Reduced
803
Closed
136

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.94B
2
AVGO icon
Broadcom
AVGO
+$2.74B
3
MSFT icon
Microsoft
MSFT
+$2.33B
4
AMD icon
Advanced Micro Devices
AMD
+$1.47B
5
GE icon
GE Aerospace
GE
+$1.27B

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.42B
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.44B
3
AAPL icon
Apple
AAPL
+$2.42B
4
FISV
Fiserv Inc
FISV
+$2.3B
5
LLY icon
Eli Lilly
LLY
+$1.78B

Sector Composition

Rank Sector Weight
1 Technology 34.73%
2 Financials 12.11%
3 Healthcare 10.97%
4 Consumer Discretionary 10.95%
5 Communication Services 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DH icon
2876
Definitive Healthcare
DH
$68.4M
$98K ﹤0.01%
24,921
+3,556
+17% +$11.2K
LUNG icon
2877
Pulmonx
LUNG
$92.8M
$98K ﹤0.01%
37,730
+1,588
+4% +$6.26K
OLPX
2878
DELISTED
Olaplex Holdings
OLPX
$98K ﹤0.01%
69,381
+7,997
+13% +$10.4K
PGEN icon
2879
Precigen
PGEN
$2.32B
$98K ﹤0.01%
68,866
+8,600
+14% +$12.2K
PLRX icon
2880
Pliant Therapeutics
PLRX
$66.9M
$98K ﹤0.01%
83,868
-3,806
-4% -$5.38K
KLTR icon
2881
Kaltura
KLTR
$243M
$97K ﹤0.01%
47,957
+4,524
+10% +$9.37K
LILA icon
2882
Liberty Latin America Class A
LILA
$1.67B
$97K ﹤0.01%
23,328
+4,248
+22% +$15.4K
WOW
2883
DELISTED
WideOpenWest
WOW
$96K ﹤0.01%
23,442
CRDF icon
2884
Cardiff Oncology
CRDF
$76.6M
$95K ﹤0.01%
30,143
+4,984
+20% +$15.2K
VSTM icon
2885
Verastem
VSTM
$604M
$95K ﹤0.01%
22,655
+4,603
+25% +$28.8K
WEST icon
2886
Westrock Coffee
WEST
$820M
$95K ﹤0.01%
16,466
FENC icon
2887
Fennec Pharmaceuticals
FENC
$423M
$94K ﹤0.01%
+11,220
New +$76.8K
INSE icon
2888
Inspired Entertainment
INSE
$164M
$94K ﹤0.01%
+11,458
New +$88.7K
TTSH
2889
DELISTED
Tile Shop Holdings
TTSH
$93K ﹤0.01%
14,553
+2,229
+18% +$13.4K
XPOF icon
2890
Xponential Fitness
XPOF
$206M
$92K ﹤0.01%
12,179
+1,904
+19% +$15.8K
ASLE icon
2891
AerSale
ASLE
$273M
$91K ﹤0.01%
15,075
CURI icon
2892
CuriosityStream
CURI
$237M
$91K ﹤0.01%
+16,076
New +$73.8K
HSHP
2893
Himalaya Shipping
HSHP
$734M
$89K ﹤0.01%
15,310
+3,179
+26% +$17.7K
MASS icon
2894
908 Devices
MASS
$418M
$89K ﹤0.01%
12,410
RGP icon
2895
Resources Connection
RGP
$145M
$89K ﹤0.01%
16,412
+1,884
+13% +$10.2K
PRTH icon
2896
Priority Technology Holdings
PRTH
$458M
$88K ﹤0.01%
+11,239
New +$84.4K
EWCZ
2897
DELISTED
European Wax Center
EWCZ
$86K ﹤0.01%
15,255
SEER icon
2898
Seer Inc
SEER
$116M
$86K ﹤0.01%
39,855
-1,045
-3% -$2.09K
UPLD icon
2899
Upland Software
UPLD
$17.9M
$86K ﹤0.01%
4,362
-38
-0.9% -$845
ALTG icon
2900
Alta Equipment Group
ALTG
$234M
$85K ﹤0.01%
13,363
+2,491
+23% +$12.6K

Similar funds

T. Rowe Price Associates's Q2 2025 Portfolio in Review

As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.

  • T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
  • T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
  • T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
  • T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
  • T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
  • T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
  • T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.

Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.